Par Drugs & Chem. Stock Price Analysis and Quick Research Report. Is Par Drugs & Chem. an attractive stock to invest in?

Stock investing requires careful analysis of financial data to determine a company's true net worth. This is generally done by examining the company's profit and loss account, balance sheet and cash flow statement, which can be time-consuming and cumbersome.

Examining a company's financial ratios is an easier way to determine its performance, which can help to make sense of the overwhelming amount of information in its financial statements. 

Here are a few indispensable ratios that should be a part of every investor’s research process, or, in simpler words, how to analyse Par Drugs & Chem.. 

• PE ratio: Price to Earnings ratio, which indicates how much an investor is willing to pay for a share for every rupee of earnings. A general rule of thumb is that shares trading at a low P/E are undervalued (it depends on other factors too). Par Drugs & Chem. has a PE ratio of 12.3008917003277 which is low and comparatively undervalued.

• Return on Assets (ROA): Return on Assets measures how effectively a company can earn a return on its investment in assets. In other words, ROA shows how efficiently a company can convert the money used to purchase assets into net income or profits. Par Drugs & Chem. has ROA of 12.0885% which is a bad sign for future performance. (Higher values are always desirable.)

• Current ratio: The current ratio measures a company's ability to pay its short-term liabilities with its short-term assets. A higher current ratio is desirable so that the company could be stable to unexpected bumps in business and economy. Par Drugs & Chem. has a Current ratio of 3.3111.

• Return on equity: ROE measures the ability of a firm to generate profits from its shareholders' investments in the company. In other words, the return on equity ratio shows how much profit each rupee of common stockholders’ equity generates. Par Drugs & Chem. has a ROE of 14.4717%. (Higher is better)

• Debt to equity ratio: It is a good metric to check out the capital structure along with its performance. Par Drugs & Chem. has a Debt to Equity ratio of 0 which means that the company has low proportion of debt in its capital.

• Sales growth: Par Drugs & Chem. has reported revenue growth of 5.5762% which is poor in relation to its growth and performance. 

• Operating Margin: This will tell you about the operational efficiency of the company. The operating margin of Par Drugs & Chem. for the current financial year is 19.3132851688809%.

• Dividend Yield: It tells us how much dividend we will receive in relation to the price of the stock. The current year dividend for Par Drugs & Chem. is Rs 0 and the yield is 0%.

• Earnings Per Share: It tells us how much profit is allocated to to each outstanding share of a common stock. The latest EPS of Par Drugs & Chem. is Rs 7.8726. The higher the EPS, the better it is for investors. 

One can find all the Financial Ratios of Par Drugs & Chem. in Ticker for free. Also, one can get the intrinsic value of Par Drugs & Chem. by using Valuation Calculators, which are available with a Finology ONE subscription. 

Par Drugs & Chem. FAQs

Q1. What is Par Drugs & Chem. share price today?
Ans: The current share price of Par Drugs & Chem. is Rs 96.84.

Q2. What is the market capitalisation of Par Drugs & Chem.?
Ans: Par Drugs & Chem. has a market capitalisation of Rs 119.158095024 Cr., calculated based on its latest share price.

Q3. What are the P/E and P/B ratios of Par Drugs & Chem.?
Ans: The PE ratio of Par Drugs & Chem. is 12.3008917003277 and the P/B ratio of Par Drugs & Chem. is 1.11956345811464, showing how the stock is valued against its earnings and book value.

Q4. What is the 52-week high and low of Par Drugs & Chem. share?
Ans: The 52-week high share price of Par Drugs & Chem. is Rs 237.45, and the 52-week low share price of Par Drugs & Chem. is Rs 81.01.

Q5. Does Par Drugs & Chem. pay dividends?
Ans: Currently, Par Drugs & Chem. does not pay dividends. Dividend yield of Par Drugs & Chem. is around 0%.

Q6. What are the face value and book value of Par Drugs & Chem. shares?
Ans: The face value of Par Drugs & Chem. shares is Rs 10, while the book value per share of Par Drugs & Chem. is around Rs 86.498. Face value is the nominal value set by the company, whereas book value reflects its accounting worth.

Q7. What is the debt of Par Drugs & Chem.?
Ans: Par Drugs & Chem. has a total debt of Rs 0 Cr., which affects investor sentiment and financial stability. 

Q8. What are the ROE and ROCE of Par Drugs & Chem.?
Ans: The ROE of Par Drugs & Chem. is 14.4717% and ROCE of Par Drugs & Chem. is 19.5063%. ROE shows how efficiently the company is generating profit from shareholders’ equity, while the ROCE is reflects how efficiently the company uses its capital to generate returns.

Q9. Is Par Drugs & Chem. a good buy for the long term?
Ans: The Par Drugs & Chem. long-term outlook depends on debt levels, earnings growth, and sector trends. If it sustains profits and manages debt well, it may be considered for long-term investment.

Q10. Is Par Drugs & Chem. undervalued or overvalued?
Ans: Based on valuation ratios like P/E, P/B, and EV/EBITDA, one can analyse whether the Par Drugs & Chem. appears undervalued or overvalued at current levels. You can check detailed valuation metrics and peer comparisons on Finology Ticker.

Q11. How to check Par Drugs & Chem.’s financials?
Ans: You can review Par Drugs & Chem.’s financial statements - including balance sheet, income statement, and quarterly results - on Finology Ticker.